In summary, miR-130b-5p exacerbates lipid accumulation and IR in NAFLD by inhibiting the AKT pathway via suppression of IGFBP2 [116]. The gene discussed is IGFBP2; the disease is metabolic dysfunction-associated steatotic liver disease.